(E)-2-((2-((4-((4-(dimethylamino)but-2-enamido)methyl)-2-methoxyphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-methylbenzamide

ID: ALA4517792

Chembl Id: CHEMBL4517792

PubChem CID: 155541038

Max Phase: Preclinical

Molecular Formula: C28H32N8O3

Molecular Weight: 528.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNC(=O)/C=C/CN(C)C)cc2OC)nc2[nH]ccc12

Standard InChI:  InChI=1S/C28H32N8O3/c1-29-27(38)19-8-5-6-9-21(19)32-26-20-13-14-30-25(20)34-28(35-26)33-22-12-11-18(16-23(22)39-4)17-31-24(37)10-7-15-36(2)3/h5-14,16H,15,17H2,1-4H3,(H,29,38)(H,31,37)(H3,30,32,33,34,35)/b10-7+

Standard InChI Key:  SWISCBWKKLIOIC-JXMROGBWSA-N

Alternative Forms

  1. Parent:

    ALA4517792

    ---

Associated Targets(Human)

GRK5 Tchem G protein-coupled receptor kinase 5 (1126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GRK2 Beta-adrenergic receptor kinase 1 (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.62Molecular Weight (Monoisotopic): 528.2597AlogP: 3.55#Rotatable Bonds: 11
Polar Surface Area: 136.30Molecular Species: BASEHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.84CX Basic pKa: 8.80CX LogP: 4.40CX LogD: 2.98
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.19Np Likeness Score: -1.12

References

1. Rowlands RA, Cato MC, Waldschmidt HV, Bouley RA, Chen Q, Avramova L, Larsen SD, Tesmer JJG, White AD..  (2019)  Structure-Based Design of Selective, Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors.,  10  (12): [PMID:31857838] [10.1021/acsmedchemlett.9b00365]

Source